16 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
supply chains for multiple products and product candidates; safety issues resulting from the administration of Regeneron's Products and Regeneron's
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
of Regeneron to manage supply chains for multiple products and product candidates; safety issues resulting from the administration of Regeneron's
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
REGN
31 May 24
to manage supply chains for multiple products and product candidates; safety issues resulting from the administration of Regeneron's Products
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
REGN
31 May 24
Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety issues resulting from
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
REGN
31 May 24
, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply
1a4gh7th s0n
REGN
31 May 24
Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety
ud9nm428i8y5vyma6en6koz
REGN
23 May 24
, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains for multiple products
a8nfztc3etiq4yzassyf2v3g4l6yy3 b1raqwhrood8rmtapw23
REGN
20 May 24
Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety issues resulting from
6wl3g9jisgg
REGN
20 May 24
, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains
t9lwi70fuzpyvh9r06tpzw83 3mpl7ugjtyy8k6unicvflz
REGN
13 May 24
Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety issues resulting from
gdx5zrfzzrhh2941owu0d6gjtz21vzlssfbki5gidwvg7h1fxbutz5ok
REGN
8 May 24
, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains
kamevmu1rv9uq6jx8h76ogtxc59jhe stua061yx20shd
REGN
2 May 24
Products and Regeneron's Product Candidates; the ability of Regeneron to manufacture and manage supply chains for multiple products and product
uyghdp m59
REGN
29 Apr 24
, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains
35vafejgwgefcr2wtr4gcfd2hkgh6b0mwsubpt8vwp
REGN
22 Apr 24
to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates
qaekadikda353ndwrt3jcasdwiet4k77ijl6knmtqugv7ny
REGN
7 Apr 24
to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety
m70 fxk7fk1
REGN
25 Mar 24
Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety issues resulting from
- Prev
- 1
- Next